{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:05:23Z","timestamp":1790366723257,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008985","name":"Diabetes Quebec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008985","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcjd.2026.04.008","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:01:34Z","timestamp":1777701694000},"page":"456-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Switching to Closed-loop Insulin Delivery System on Glycemic Management and Quality of Life in Adults Living With Cystic Fibrosis\u2013related Diabetes"],"prefix":"10.1016","volume":"50","author":[{"given":"Alan\u00efs","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Girouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4549-699X","authenticated-orcid":false,"given":"Laure","family":"Alexandre-Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-8060","authenticated-orcid":false,"given":"Ad\u00e8le","family":"Coriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2026.04.008_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcjd.2024.09.001","article-title":"Cystic fibrosis\u2013related diabetes: A first Canadian clinical practice guideline","volume":"49","author":"Coriati","year":"2025","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2026.04.008_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/dmrr.2429","article-title":"Cystic fibrosis-related diabetes compared with type 1 and type 2 diabetes in adults","volume":"29","author":"Konrad","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jcjd.2026.04.008_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/193229681200600507","article-title":"Cystic fibrosis-related diabetes in adults: Inpatient management of 121 patients during 410 admissions","volume":"6","author":"Rasouli","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcjd.2026.04.008_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1746.2002.02755.x","article-title":"Clinical implications of hepatogenous diabetes in liver cirrhosis","volume":"17","author":"Holstein","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcjd.2026.04.008_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1347141","article-title":"Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: A pilot study","volume":"15","author":"Bassi","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2026.04.008_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/dia.2025.0075","article-title":"The effect of Omnipod 5 automated insulin delivery on glycemic control in adolescents and adults with cystic fibrosis-related diabetes","volume":"27","author":"Scully","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcjd.2026.04.008_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1228153","article-title":"Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes","volume":"14","author":"Grancini","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2026.04.008_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00592-024-02329-7","article-title":"Offlabel use of Medtronic MiniMed 780G in the management of cystic fibrosis related diabetes in people requiring insulin total daily doses below 8 units: Encouraging data from our population","volume":"61","author":"Grancini","year":"2024","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcjd.2026.04.008_bib11","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267126000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267126000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:53:33Z","timestamp":1790366013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267126000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1499267126000730"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.04.008","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Switching to Closed-loop Insulin Delivery System on Glycemic Management and Quality of Life in Adults Living With Cystic Fibrosis\u2013related Diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published on behalf of Diabetes Canada.","name":"copyright","label":"Copyright"}]}}